Syndax Pharmaceuticals, Inc. (SNDX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Syndax Pharmaceuticals, Inc. (SNDX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

SNDX Income Statement

Syndax Pharmaceuticals, Inc. (SNDX) annual income statement — 15-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	72.79M	64.86M	68.48M	45.87M	37.96M	20.04M	7.68M	12.5M	3.5M	0	0	0	0	0	0	0	0	0	126.58M	12.38M
Revenue Growth %	91.76%	223.64%	791.68%	266.97%	984.51%	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	33209.47%	3165.17%
Cost of Goods Sold	3.21M	2.63M	-1.57M	2.1M	1.28M	885K	0	0	0	0	0	0	0	0	0	0	0	0	121K	0
COGS % of Revenue	4.41%	4.06%	-2.3%	4.58%	3.37%	4.42%	-	-	-	-	-	-	-	-	-	-	-	-	0.1%	-
Gross Profit	69.58M	62.23M	70.05M	43.77M	36.68M	19.16M	7.68M	12.5M	3.5M	0	0	0	0	0	0	0	0	0	126.45M	12.38M
Gross Margin %	95.59%	95.94%	102.3%	95.42%	96.63%	95.58%	100%	100%	100%	-	-	-	-	-	-	-	-	-	99.9%	100%
Gross Profit Growth %	89.7%	224.85%	812.15%	250.17%	947.97%	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	33265.44%	3165.17%
Operating Expenses	109.58M	96.43M	132.6M	101.2M	106.03M	102.91M	104.05M	102.08M	77.72M	79.51M	77.91M	56.35M	49.68M	46.02M	42.03M	35.14M	37.72M	36.86M	30.83M	32.41M
OpEx % of Revenue	150.54%	148.67%	193.63%	220.61%	279.34%	513.49%	1354.75%	816.62%	2220.46%	-	-	-	-	-	-	-	-	-	24.35%	261.87%
Selling, General & Admin	41.54M	37.59M	49.93M	44.92M	43.8M	41.03M	37.69M	31.11M	29.06M	23.02M	22.78M	17.27M	14.91M	11.96M	10.19M	8.24M	7.99M	6.84M	6.93M	6.8M
SG&A % of Revenue	57.07%	57.95%	72.91%	97.92%	115.4%	204.73%	490.76%	248.85%	830.31%	-	-	-	-	-	-	-	-	-	5.47%	54.96%
Research & Development	68.04M	58.84M	78.64M	56.28M	62.23M	61.64M	65.53M	70.97M	48.66M	56.49M	55.13M	39.09M	34.76M	34.05M	31.84M	26.9M	29.73M	30.02M	23.9M	25.61M
R&D % of Revenue	93.47%	90.72%	114.84%	122.69%	163.94%	307.53%	853.24%	567.77%	1390.14%	-	-	-	-	-	-	-	-	-	18.88%	206.92%
Other Operating Expenses	0	0	1000K	0	0	247K	826K	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-39.99M	-34.2M	-62.55M	-57.43M	-69.35M	-83.76M	-96.36M	-89.58M	-74.22M	-79.51M	-77.91M	-56.35M	-49.68M	-46.02M	-42.03M	-35.14M	-37.72M	-36.86M	95.75M	-20.03M
Operating Margin %	-54.95%	-52.73%	-91.34%	-125.19%	-182.71%	-417.91%	-1254.75%	-716.62%	-2120.46%	-	-	-	-	-	-	-	-	-	75.65%	-161.87%
Operating Income Growth %	42.33%	59.17%	35.09%	35.89%	6.55%	-5.34%	-23.7%	-58.95%	-49.39%	-72.8%	-85.34%	-60.37%	-31.69%	-24.84%	-143.9%	-75.42%	-68.91%	-35.69%	582.12%	-0.9%
EBITDA	-36.69M	-34.2M	-62.55M	-57.42M	-69.3M	-74.62M	-89.36M	-89.58M	-74.21M	-79.51M	-77.9M	-56.35M	-49.67M	-46.01M	-42.03M	-35.13M	-37.71M	-36.85M	95.87M	-20.02M
EBITDA Margin %	-50.4%	-52.72%	-91.33%	-125.18%	-182.56%	-372.31%	-1163.58%	-716.6%	-2120.37%	-	-	-	-	-	-	-	-	-	75.74%	-161.81%
EBITDA Growth %	47.06%	54.17%	30.01%	35.89%	6.62%	6.15%	-14.71%	-58.96%	-49.4%	-72.8%	-85.35%	-60.4%	-31.72%	-24.87%	-143.84%	-75.45%	-69.66%	-36.24%	583.24%	-0.98%
D&A (Non-Cash Add-back)	0	4K	3K	3K	55K	9.14M	0	2K	3K	3K	3K	3K	3K	3K	3K	8K	11K	11K	121K	8K
EBIT	-36.69M	-30.83M	-15.31M	-52.43M	-63.99M	-92.89M	-89.36M	-84.1M	-68.02M	-72.34M	-72.41M	-51.08M	-44.58M	-41.09M	-39.15M	-33.66M	-36.88M	-36.52M	96.2M	-19.99M
Net Interest Income	-8.92M	-8.29M	-43.1M	-3.01M	-1.91M	-868K	2.3M	5.42M	6.24M	7.2M	5.49M	5.28M	5.16M	5.04M	2.94M	33K	183K	-427K	91K	-566K
Interest Income	3.75M	3.56M	9.6M	5.27M	5.95M	7.18M	7.11M	5.44M	6.28M	7.26M	5.55M	5.34M	5.19M	5.08M	2.99M	1.78M	878K	224K	91K	83K
Interest Expense	12.68M	11.85M	52.7M	8.28M	7.86M	8.05M	4.81M	23K	45K	55K	63K	70K	35K	40K	43K	1.75M	695K	651K	0	649K
Other Income/Expense	-9.37M	-8.47M	-5.47M	-3.29M	-2.49M	-1.09M	2.2M	5.45M	6.15M	7.11M	5.43M	5.21M	5.06M	4.89M	2.84M	-262K	152K	-311K	449K	-607K
Pretax Income	-49.36M	-42.67M	-68.01M	-60.72M	-71.85M	-84.85M	-94.17M	-84.13M	-68.06M	-72.4M	-72.47M	-51.15M	-44.62M	-41.13M	-39.19M	-35.4M	-37.57M	-37.17M	96.2M	-20.64M
Pretax Margin %	-67.82%	-65.79%	-99.32%	-132.36%	-189.28%	-423.34%	-1226.16%	-673.01%	-1944.66%	-	-	-	-	-	-	-	-	-	76%	-166.78%
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-49.36M	-42.67M	-68.01M	-60.72M	-71.85M	-84.85M	-94.17M	-84.13M	-68.06M	-72.4M	-72.47M	-51.15M	-44.62M	-41.13M	-39.19M	-35.4M	-37.57M	-37.17M	96.2M	-20.64M
Net Margin %	-67.82%	-65.79%	-99.32%	-132.36%	-189.28%	-423.34%	-1226.16%	-673.01%	-1944.66%	-	-	-	-	-	-	-	-	-	76%	-166.78%
Net Income Growth %	31.29%	49.71%	27.77%	27.83%	-5.56%	-17.19%	-29.94%	-64.48%	-52.56%	-76.04%	-84.91%	-44.47%	-18.75%	-10.65%	-140.74%	-71.53%	-64%	-34.07%	571.03%	-0.99%
Net Income (Continuing)	-49.36M	-42.67M	-68.01M	-60.72M	-71.85M	-84.85M	-94.17M	-84.13M	-68.06M	-72.4M	-72.47M	-51.15M	-44.62M	-41.13M	-39.19M	-35.4M	-37.57M	-37.17M	96.2M	-20.64M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.55	-0.49	-0.78	-0.70	-0.83	-0.99	-1.10	-0.98	-0.80	-0.85	-1.00	-0.73	-0.64	-0.59	-0.62	-0.58	-0.62	-0.63	1.81	-0.40
EPS Growth %	33.73%	50.51%	29.09%	28.57%	-3.75%	-16.47%	-10%	-34.25%	-25%	-44.07%	-61.29%	-25.86%	-3.23%	6.35%	-134.25%	-45%	-40.91%	-16.67%	511.36%	13.04%
EPS (Basic)	-0.55	-0.49	-0.78	-0.70	-0.83	-0.99	-1.10	-0.98	-0.80	-0.85	-1.00	-0.73	-0.64	-0.59	-0.62	-0.58	-0.62	-0.63	1.81	-0.40
Diluted Shares Outstanding	88.99M	86.62M	86.62M	86.62M	86.34M	85.62M	85.79M	85.43M	85.27M	85.21M	72.52M	69.86M	69.64M	69.44M	63.19M	60.67M	60.16M	58.98M	53.18M	51.96M
Basic Shares Outstanding	88.99M	86.62M	86.62M	86.62M	86.34M	85.62M	85.79M	85.43M	85.27M	85.21M	72.52M	69.86M	69.64M	69.44M	63.19M	60.67M	60.16M	58.98M	51.79M	51.96M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-